Tirzepatide emerges a groundbreaking treatment agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://jadaswys302877.smblogsites.com/40663683/tirzepatide-a-new-frontier-in-diabetes-treatment